Gilead Sciences investit 320 millions de dollars dans Arcus Biosciences, portant sa participation à 33 %, et modifie l'accord de collaboration, le CCO de Gilead rejoignant le conseil d'administration d'Arcus. Gilead Sciences invests $320M in Arcus Biosciences, increasing ownership to 33%, and amends collaboration agreement, with Gilead's CCO joining Arcus's board.

Gilead Sciences a investi 320 millions de dollars dans Arcus Biosciences, augmentant ainsi sa participation dans la société à 33 %. Gilead Sciences has invested $320 million in Arcus Biosciences, increasing its ownership stake in the company to 33%. Cet investissement, ainsi que les modifications apportées à leur accord de collaboration, accéléreront la croissance des programmes de développement conjoints des sociétés dans de multiples indications. This investment, along with amendments to their collaboration agreement, will accelerate the growth of the companies' joint development programs across multiple indications. De plus, le directeur commercial de Gilead rejoindra le conseil d'administration d'Arcus. Additionally, Gilead's Chief Commercial Officer will join Arcus's board.

January 29, 2024

14 Articles